India, July 17 -- Did you know that nearly 4 in 10 Indian adults suffer from fatty liver disease? Now the Central Drugs ...

July 17 (Reuters) - Danish drugmaker Novo Nordisk said on Friday that India's drug regulator has approved its obesity drug ...

Wegovy is a glucagon-like peptide-1 (GLP-1) receptor agonist manufactured by Novo Nordisk that is approved by the U.S. Food ...

Add Yahoo as a preferred source to see more of our stories on Google. Patients with a prescription can now purchase the lowest dose of the new Wegovy pill. - Novo Nordisk Americans can now purchase ...

The CDSCO has approved a new indication for Wegovy (semaglutide injection 2.4 mg) for treatment of noncirrhotic metabolic ...

A WEIGHT-LOSS pill goes on sale for the first time today in a further milestone in the war on obesity. Tens of thousands are ...

Novo Nordisk's Wegovy receives CDSCO approval as India's first GLP-1 treatment for fatty liver disease, addressing rising ...

Contrave and Wegovy are two prescription medications approved by the U.S. Food and Drug Administration (FDA) for weight loss, but their mechanisms of action are very different. Here, Forbes Health ...

MOVE over fat jabs – there’s a new weight loss ‘wonder’ in town. The Wegovy tablet is now officially on sale in the UK, ...

India's drug regulator has approved Novo Nordisk's obesity drug Wegovy to treat MASH, a progressive fatty liver disease ...

The approval comes as fatty liver disease emerges as a major public health concern, with nearly two in three Indians ...